HeartSciences' MyoVista® wavECGTM Selected to be used in Irish Heart Screening EvaluationGlobeNewsWire • 08/24/23
HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent PortfolioGlobeNewsWire • 08/17/23
HeartSciences Provides Business Update and Reports Fiscal 2023 Financial ResultsGlobeNewsWire • 07/19/23
HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook MagazineGlobeNewsWire • 05/17/23
HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECGGlobeNewsWire • 05/09/23
HeartSciences to Participate in The Benchmark Company's Virtual Individual Investor Healthcare ConferenceGlobeNewsWire • 05/02/23
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial ResultsGlobeNewsWire • 03/16/23
HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific TimeGlobeNewsWire • 02/07/23
HSCS Stock Alert: HeartSciences Receives Israeli Patent for AI Heart-Disease DetectorInvestorPlace • 02/06/23
HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart DiseaseGlobeNewsWire • 02/06/23
Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25thGlobeNewsWire • 01/23/23
HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25thGlobeNewsWire • 01/20/23
HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance ExecutiveGlobeNewsWire • 01/04/23
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial ResultsGlobeNewsWire • 12/16/22
HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG AlgorithmsGlobeNewsWire • 12/01/22
HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022GlobeNewsWire • 11/28/22
HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022GlobeNewsWire • 11/21/22
HeartSciences' MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular EventsGlobeNewsWire • 11/10/22
HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECGGlobeNewsWire • 10/25/22